Date Title Description PDF
26 Jul 2023 On buy-back programmes The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.   Download
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download

Pages

Date Title Description PDF
26 Feb 2020 Annual Corporate Governance Report ROVI releases the 2019 Annual Corporate Governance Report Download
26 Feb 2020 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2019 annual report regarding remuneration of the members of the Board of Directors  Download

Pages

Date Title Description PDF
25 Jul 2017 Otros sobre Gobierno Corporativo The Company informes about the modification of the Internal code of conduct Download
10 Jul 2017 Contratos de liquidez y contrapartida (2) The Company informs that has signed a new liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. Download
10 Jul 2017 Contratos de liquidez y contrapartida (1) The Company informs that has cancelled the liquidity contract with JB Capital Markets, Sociedad de Valores, S.A.U. Download
04 Jul 2017 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the second quarter of 2017 Download
23 Jun 2017 Información sobre dividendos The Company informes about the dividends payment Download

Pages